Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs
- PMID: 15315909
- DOI: 10.1152/ajpendo.00313.2004
Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs
Abstract
Intraportal delivery of serotonin enhanced net hepatic glucose uptake (NHGU) during a hyperinsulinemic hyperglycemic clamp, but serotonin elevated catecholamines and can cause gastrointestinal distress. We hypothesized that the selective serotonin reuptake inhibitor (SSRI) fluvoxamine would enhance NHGU without side effects. Arteriovenous difference and tracer ([3-(3)H]glucose) techniques were used in conscious 42-h-fasted dogs. Experiments consisted of equilibration (-120 to -30 min), basal (-30 to 0 min), and experimental (EXP; 0-270 min) periods. During EXP, somatostatin, fourfold basal intraportal insulin, basal intraportal glucagon, and peripheral glucose (to double the hepatic glucose load) were infused. Saline (SAL) was infused intraportally during 0-90 min (P1), and fluvoxamine was infused intraportally at 0.5, 1, and 2 mug.kg(-1).min(-1) from 90 to 150 (P2), 150 to 210 (P3), and 210 to 270 (P4) min, respectively, in the FLUV group (n = 8). The SAL group (n = 9) received intraportal saline during 0-270 min. NHGU in SAL was 13.9 +/- 1.7 and 17.0 +/- 2.0 mumol.kg(-1).min(-1) in P3-P4, respectively, while NHGU in FLUV averaged 19.7 +/- 2.8 and 26.6 +/- 3.0 mumol.kg(-1).min(-1) (P < 0.05 vs. SAL). Net hepatic carbon retention was greater (P < 0.05) in FLUV than in SAL (17.6 +/- 2.6 vs. 13.9 +/- 2.7 and 23.8 +/- 3.0 vs. 14.4 +/- 3.3 mumol.kg(-1).min(-1) in P3-P4, respectively), and final hepatic glycogen concentrations were 50% greater in FLUV (P < 0.005). Nonhepatic glucose uptake was greater in SAL than in FLUV at 270 min (P < 0.05). Catecholamine concentrations remained basal, and the animals evidenced no distress. Thus fluvoxamine enhanced NHGU and hepatic carbon storage without raising circulating serotonin concentrations or causing stress, suggesting that hepatic-targeted SSRIs might be effective in reducing postprandial hyperglycemia in individuals with diabetes or impaired glucose tolerance.
Similar articles
-
Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E225-31. doi: 10.1152/ajpendo.00614.2004. Epub 2005 Mar 8. Am J Physiol Endocrinol Metab. 2005. PMID: 15755767 Free PMC article.
-
Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E556-63. doi: 10.1152/ajpendo.00405.2004. Epub 2004 Nov 2. Am J Physiol Endocrinol Metab. 2005. PMID: 15522992
-
Portal serotonin infusion and glucose disposal in conscious dogs.Diabetes. 2004 Jan;53(1):14-20. doi: 10.2337/diabetes.53.1.14. Diabetes. 2004. PMID: 14693692
-
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.Eur J Pharmacol. 2009 Apr 1;607(1-3):251-7. doi: 10.1016/j.ejphar.2009.01.042. Eur J Pharmacol. 2009. PMID: 19326481 Free PMC article.
-
Regulation of hepatic glucose uptake and storage in vivo.Adv Nutr. 2012 May 1;3(3):286-94. doi: 10.3945/an.112.002089. Adv Nutr. 2012. PMID: 22585902 Free PMC article. Review.
Cited by
-
Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.Diabetologia. 2007 Aug;50(8):1743-51. doi: 10.1007/s00125-007-0696-y. Epub 2007 Jun 20. Diabetologia. 2007. PMID: 17579833
-
Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.Am J Physiol Endocrinol Metab. 2013 Apr 1;304(7):E747-56. doi: 10.1152/ajpendo.00639.2012. Epub 2013 Feb 12. Am J Physiol Endocrinol Metab. 2013. PMID: 23403942 Free PMC article.
-
Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E225-31. doi: 10.1152/ajpendo.00614.2004. Epub 2005 Mar 8. Am J Physiol Endocrinol Metab. 2005. PMID: 15755767 Free PMC article.
-
Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E132-9. doi: 10.1152/ajpendo.00160.2013. Epub 2013 May 14. Am J Physiol Endocrinol Metab. 2013. PMID: 23673158 Free PMC article.
-
Serotonin (5-HT) affects expression of liver metabolic enzymes and mammary gland glucose transporters during the transition from pregnancy to lactation.PLoS One. 2013;8(2):e57847. doi: 10.1371/journal.pone.0057847. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23469086 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous